Introduction
Adoptive immunotherapy with allogeneic or donor T cells after stem cell transplantation has been successfully applied both in infectious and malignant diseases. 1, 2 Donor T cell clones recognizing human cytomegalovirus are used for preventing virus disease after bone marrow transplantation. 3, 4 Moreover, Epstein-Barr virus (EBV)-related post-transplantation lymphomas can be treated with EBV-specific cytotoxic T cells from the donor. [5] [6] [7] [8] Transfusion of allogeneic or donor T cells after stem cell transplantation is an efficient treatment modality for persisting or relapsing residual leukemic disease and other hematological disorders. [9] [10] [11] [12] [13] [14] [15] The clinical benefit of the graft-versus-leukemia effect is limited by the complication of graft-versus-host disease which can hardly be controlled by conventional therapy.
Suicide gene expression has been suggested for the targeted elimination of the grafted cells in the case of complications such as graft-versus-host disease. 16 The herpes simplex virus type 1 (HSV-1) gene thymidine kinase (tk), whose gene product activates ganciclovir (GCV) to a toxic metabolite, or the E. coli gene cytosine deaminase (cd), which leads to conversion of non-toxic 5-fluorocyto-
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Received 12 August 1999; accepted 21 December 1999 ated in the presence of low concentrations of ganciclovir. This elimination mechanism remained fully functional over an observation period of 12 months. The potentially immunogenic neomycin resistance gene expression cassette was deleted from the genome of established mutant viruses by using the prokaryotic Cre/LoxP recombination system. At any time during the course of a therapeutic application, thymidine kinase-expressing transformed human T cells might be eliminated after administration of ganciclovir. In principle, this function could be useful for the T cell-dependent immunotherapy of resistant blood cancer while avoiding the risk of uncontrolled graft-versus-host disease. Gene Therapy (2000) 7, 664-674.
sine (5-FC) to toxic 5-fluorouracil (5-FU), are frequently applied as suicide genes. By the use of retroviral vectors, the tk gene was transduced into the donor T cells before transplantation. 5, 17, 18 In three patients who developed graft-versus-host disease, the administration of GCV eliminated the grafted T cells and stopped the acute clinical complications. 5, 19 Further clinical trials are being performed in order to test the clinical benefit of this approach. [19] [20] [21] The transfer of heterologous genes into human T cells is technically demanding. Transduction of activated human T cells is achieved with conventional retrovirus vectors only by using additional techniques. Many investigators use chemical selection pressure, eg, with G418 via the neomycin resistance gene (neo r
. 17 An overexpression system for the production of vector particles and for improved transduction of T cells has been reported recently. 22 Another method uses the coexpression of an inert surface marker in order to positively select the transduced T cells which express both the surface marker and the heterologous gene of interest. 5, 19, 23 The retroviral gene transfer into human T cells can be limited by either low transduction efficiencies or by low expression rates. Poor expression rates can result from integration into inactive genomic regions or from secondary inactivation. There is little experience concerning a reliable long-term functionality of retrovirally transduced transgenes such as tk in primary human T cells. Thus, alternatives should be considered and functionally compared with the currently applied routine strategies.
665
Herpesvirus saimiri, a ␥ 2 -herpesvirus of squirrel monkeys, 24 was successfully used as a vector for delivering bovine growth hormone in an early gene therapy study in non-human primates. 25 Subsequently, this virus was applied as a T cell vector in order to study oncogenic functions of human T cell leukemia virus (HTLV-1). [26] [27] [28] [29] [30] [31] Herpesvirus saimiri offers two specific advantages over integrating retroviral vectors. First, the virus does not integrate into the cellular genome and persists episomally in high and stable copy number. [32] [33] [34] Dilution effects or loss of the episomal DNA has never been observed in human T cells. Second, the virus strain C488 is able to transform human T cells to stable growth in culture. 32 In contrast to leukemic cell lines or to HTLV-1 immortalized T cells, the herpesvirus-transformed human T lymphocytes retain a high degree of functionality including the MHC-restricted antigen-specific reactivity of parental non-infected T cell clones. [35] [36] [37] [38] [39] There is only little virus gene expression and no virion production in these T cells. 33, 40 The C488-transformed human T cells appear to be non-tumorigenic. Large amounts of autologous transformed T cells were reinfused into the donor macaques and were well tolerated without occurrence of lymphoma or leukemia. 41 Thus, we consider herpesvirus saimiri to be an interesting tool for stable gene transfer into human T cells, at least for in vitro studies and possibly also for clinical applications in the future.
In this report, we show that herpesvirus saimiri vectors allow the functional long-term expression of heterologous genes after infection of primary human and simian T cells. After administration of GCV, human T cells carrying the tk gene on non-integrated herpesviral episomal genomes were efficiently eliminated. This switch-off function of the transduced cell lines was reliable for an observation period of 1 year and might provide an important step towards a possible application of herpesvirus saimiri vectors in adoptive immunotherapy.
Results
Recombinant herpesvirus saimiri vectors for suicide genes A novel recombination vector (pRecosac, Figure 1a ) was constructed in order to facilitate homologous recombination into the terminal genomic transition region from coding unique L-DNA to non-coding, repetitive H-DNA of herpesvirus saimiri (L: low CG content; H: high CG content). The 5.5 kb terminal L-DNA fragment of herpesvirus saimiri comprising the viral genes orf74 and orf75 and the L-/H-DNA transition region was applied to mediate efficient homologous recombination. We used the respective region of strain A11, because convenient restriction enzyme recognition sites (SacII and SmaI) were available and the nucleotide sequence (5.5 kb) was found to be almost identical between virus strains A11 and C488 (96.7% conservation). The SV40 enhancer-regulated neo r gene was used for the positive selection of recombinant viruses. The neo r gene was inserted with flanking LoxP recognition sites for the prokaryotic recombinase Cre. pRecosac carries four unique cleavage sites for cloning heterologous genes between the mentioned vector components. Phosphoglycerate kinase-1 (pgk-1) promoter-driven expression cassettes for the suicide genes tk of HSV-1 or cd of E. coli were inserted in both orientations Gene Therapy into pRecosac resulting in the recombination plasmids pRecoTK+, pRecoTK−, pRecoCD+ and pRecoCD−. Permissive owl monkey kidney (OMK) cells were transfected with linearized DNA of the recombination constructs and subsequently infected with herpesvirus saimiri C488 in order to allow homologous crossover events (Figure 1b) . The resulting recombinant viruses were selected in the presence of G418 in OMK cells and cloned by plaque purification. Clonal virus recombinants were analyzed by Southern blot hybridization for the absence of wild-type virus and for the presence of transgene-specific bands (Figure 2a) .
The recombinant virus TK-2 was compared with wildtype virus C488 with respect to drug sensitivity ( Figure  2b ). The inhibition of virus replication was analyzed in the presence of acyclovir (ACV) or ganciclovir (GCV). Wild-type virus C488 was hardly affected, even by high concentrations of either drug. The replication of TK-2 as measured with the limiting dilution titer was severely inhibited by a factor of up to 10 3 . In these assays, GCV was more efficient than ACV on the mutant virus TK-2; higher concentrations of ACV were needed in comparison with GCV to reach the same level of inhibition. The weak inhibition observed for the wild-type virus replication under high GCV concentrations (500 or 1000 m) indicated a weak endogenous TK function of herpesvirus saimiri. In fact, the respective genes, orf21 and orf36, are transcribed under lytical conditions, as shown by RT-PCR (Figure 3d ).
Transduction and targeted elimination of human and simian T cells A choice of clonal recombinant tk and cd viruses with both transgene orientations were selected for infection of human and simian T cells ( Table 1 ). The growth transformation procedure was generally highly efficient with the exception of TK-expressing viruses carrying the transgene in positive orientation (TK+1, TK+2). In this case, transformed human T cell lines were not obtained, whereas simian T cells were readily transformed. The (−) orientation of the TK transgene was superior to the (+) orientation, especially in the absence of virus replication as in human T cells. The transformed human T cells had a doubling time of 3 to 7 days and were CD3 + and either
− . The presence of the respective transgene (tk or cd) was demonstrated in the transformed T cells by PCR. Figure  3a shows the results for tk-transduced human T cells. The transcription of the suicide genes (tk and cd) was analyzed by RNase protection assays from total cellular RNA. A doublet of bands of expected size indicated the correctly initiated tk transcripts driven by the pgk-1 promoter (Figure 3b ). The signal intensities were similiar, whether the gene was transcribed after stable transfection into OMK cells or under semipermissive (transformed tamarin T cells) or non-permissive persistent conditions in human T cells. Similar results were observed for cd transcription (data not shown). The suicide gene products, the enzymes TK and CD, were demonstrated by Western blotting. CD protein was shown by using a monoclonal antibody (data not shown). TK protein was detected with a polyclonal antiserum which produced high signal intensities under lytic (infected OMK cells), semipermissive (tamarin T cells), and non-permissive persistent (human T cells) conditions (Figure 3c ). 
Figure 2 Herpesvirus saimiri mutants carrying the thymidine kinase gene. (a) Southern blot hybridization of PstI-digested virion DNA of recombinant (TK+1, TK+2, TK−2, TK−4) or wild-type (C488) viruses. The signals produced by a 32 P-labeled HSV-1 tk gene probe correspond to the PstI fragment sizes given in Figure 1a and indicate that the entire tk expression construct was inserted. (b) Replication inhibition of the wild-type virus or the TKexpressing recombinant TK-2 in the presence of acyclovir (ACV) or ganciclovir (GCV). In 24-well plates log 10 dilutions of virus supernatants were tested as quadruplicates on fresh OMK monolayers. As readout parameter, the respective dilution step was monitored which led to infection and complete lysis of the cells in at least two of the four parallel wells. The replication of the recombinant virus TK-2 is severely inhibited by a factor of up to 10
3 , whereas wild-type virus C488 is little affected by these drugs. Thus, the endogenous ACV/GCV kinase activity of herpesvirus saimiri is comparably low and only detected at high drug concentrations, but correlates with expression of the genes orf21 and orf36 (Figure 3d ).
Under permissive conditions in lytically infected OMK cells or in semipermissive-transformed tamarin T cells, the herpesvirus saimiri genes orf21 and orf36 were shown to be transcribed ( Figure 3d ) by RT-PCR after removal of virus DNA from the RNA samples by DNase digestion. In parallel, these RNA samples were tested by PCR without previous reverse transcription and were shown to be free of residual virus DNA. Under non-permissive conditions, these virus genes were not expressed. Semipermissive monkey T cells lost permissivity and expression of orf21 and orf36 after long-term cultivation.
As soon as growth transformation became evident and over 1 year of observation, the effect of the respective prodrugs GCV, ACV or 5-FC was analyzed on simian or human T cells. Wild-type and mutant virus-infected T cells were exposed to increasing prodrug concentrations and measured for proliferation by uptake of radioactive 3 H thymidine (Table 2; Figure 4 ). The 100% values of pro- liferation represent the endogenous DNA synthesis activity and basal proliferation without additional stimulation and in the absence of exogenous interleukin-2 (IL-2). A decrease of thymidine uptake reflects primarily the inhibition of DNA synthesis by the activated prodrugs, and subsequently cell death. Although the cd gene had been shown to have the correct sequence, and cd transcripts as well as CD protein expression had been demonstrated, 5-FC did not exert any effect on cd mutant virustransformed simian or human T cells. However, both CDGene Therapy expressing and control T cells were highly sensitive to treatment with 5-FU which is the toxic derivative of the prodrug 5-FC. In contrast, tk-transduced simian and human T cells were highly sensitive to GCV and to a lesser extent to ACV, whereas wild-type virus-transformed control T cells were only weakly affected (Figure 4a , b, d). Three different parallel TK-expressing cultures of human CB cells had comparable GCV sensitivity in elimination tests. Control experiments with non-transformed human T cells indicated a higher susceptibility to GCV- 
Figure 3 Characterization of herpesvirus saimiri transformed T cell lines. (a) Presence of the tk gene. The presence of the tk gene in transformed human T cells derived from cord blood (CB) is shown by DNA-PCR from cell lysates by a 500 bp band. The plasmid pRecoTK+ served as positive control, uninfected and C488-transformed T cells as negative controls. (b) tk gene transcription. The transcription of the HSV-1 tk gene was shown by RNase protection assays. A doublet of bands of expected size shows the correctly initiated tk transcripts driven by the pgk-1 promoter. The undigested antisense riboprobe and a labeled DNA marker (M) are shown for comparison. Total cellular RNA samples were analyzed from tk-transfected OMK cells, from C488 or tk-recombinant transformed human CB T cells or simian B133 T cells. (c) TK protein expression. The TK protein was demonstrated by Western blotting with a TK antiserum and chemoluminescence. Lysates from transiently tk-transfected COS-7 and stably transfected OMK cells served as positive and lysates from uninfected simian B133 T cells as negative control. TK protein is shown from infected OMK cells and from mutant virus-transformed simian (B133) and human (CB) T cells. (d) Expression of the herpesvirus saimiri genes orf21 and orf36. The expression of the virus genes encoding endogenous TK function was examined by RT-PCR after DNase treatment of the RNA samples in order to remove any traces of virus DNA. Both virus genes were found to be transcribed under permissive conditions, such as infected permissive OMK cells, or semipermissive-transformed New World monkey cells (B133 C488; B133 TK-2). After prolonged cultivation, transformed simian T cells stopped virus release and expression of the genes orf21 and orf36, as shown for the long-term cultivated virus-transformed marmoset T cell lines
The transformed T cell lines were subjected to elimination experiments in the presence of the relevant prodrug. N indicates that no elimination was observed. E describes that drug-induced elimination was achieved (proliferation reduced to Ͻ20% at 100 m GCV or 5-FC).
Increasing concentrations of the drugs GCV or 5-FC (from 10 m to at least 200 m) were applied in the elimination experiments in order to induce cell death which was measured as reduced thymidine incorporation values (Figure 4 ). The tests were performed 2-4 months after infection and confirmed in most cases after longer time-periods (up to 1 year). E/N indicates that the wild-type-transformed control cells were initially sensitive to GCV, as long as endogenous TK/GCV kinase activity was present and orf21 and orf36 were transcribed. After prolonged cultivation, when virus production had stopped, the control cultures were no longer sensitive to GCV treatment (see Figure 4c and d). Since herpesvirus saimiri-transformed tamarin T cells are semipermissive and shed virus particles they express many virus genes. Correspondingly, an endogenous TK or GCV kinase activity was observed which is probably due to the expression of the herpesvirus saimiri genes orf21 and orf36 (Figure 3d ). As long as these monkey T cells produced virus particles, there was only little difference between wild-type and recombinant infected cells (Figure 4c ). After 12 months, when the transformed tamarin T cells had lost their ability to produce virus particles and, correspondingly, their endogenous TK activity, the wild-type transformed simian cells were no longer sensitive to GCV treatment (Figure 4d) . Expression of the virus genes orf21 and orf36 was no longer detectable after prolonged cultivation (Figure 3d ). In contrast, transformed human T cells did not produce virion particles and did not show a relevant background sensitivity to GCV (Figure 4a and b) .
Deletion of possible immunogenic vector components pRecosac harbors the neo r gene between flanking LoxP recognition sites for the prokaryotic recombinase Cre. OMK cells were stably transfected with a Cre expression vector derived from pBS185. OMK clones which yielded DNA-PCR signals for the transfected cre gene were further prescreened for Cre activity by transient transfection of the plasmid pRecosac. Cre activity was estimated by the shortening of an appropriate PCR product which indicated that the sequence flanked by LoxP sites had been deleted. Functionally selected OMKCre clones were infected by the recombinant TK viruses TK-2 and TK-4. By Southern blot analysis, the efficient Cre recombinasemediated deletion of the neo r gene was demonstrated ( Figure 5) . The large tk-containing SacII fragment was shortened, and the neo r -containing ApaI fragment (2.8 kb) was lost, whereas the short SacII fragment of about 460 bp remained unaffected. Subsequently, neo r -deleted TKexpressing recombinant viruses were used to infect primary human T cells and yielded transformed T cell lines with full GCV sensitivity.
Discussion
In this study, we demonstrate that vectors based on herpesvirus saimiri provide reliable means for the functional long-term expression of heterologous genes in human T lymphocytes. The GCV-mediated elimination of tk-transduced human T cells was stably efficient over 1 year of observation. This might form the basis for therapeutic applications in future, eg for allogeneic immunotherapy of hematological disorders and malignancies such as residual leukemia.
Herpesvirus saimiri vectors stably persist in human T cells in episomal form without genomic integration, which excludes problems arising from chromosomal integration such as insertional mutagenesis and silencing upon chromatin inactivation. Human T cells proliferate spontaneously in culture after infection with herpesvirus saimiri C488. 42 However, they retain a remarkably normal phenotype and closely resemble native IL-2-depenGene Therapy dent non-transformed T cells. The sensitivity to various apoptosis stimuli was unchanged. 43 Stimulation of the growth-transformed T cells leads to enhanced cytokine production and cytotoxicity. Among many preserved relevant functions of normal T cells, the MHC-restricted antigen specificity of parental T cell clones is the most important feature. [35] [36] [37] [38] [39] A broad variety of T cell subtypes can be transformed, either CD4 + or CD8 + cells, and either ␣␤-or ␥␦-T cells. 32, 37, [44] [45] [46] [47] When polyclonal bulk cultures had been infected with the virus, a broad spectrum of V␤ chains was represented in the resulting transformed cultures. 48 The growth-transformed human T cells are not permissive to the virus and do not produce virion particles. Correspondingly, only few virus genes are expressed after transformation. 33, 40 One of them is the oncogene stpC whose gene product interacts with cellular Ras, transforms rodent fibroblasts, and causes tumors in transgenic mice. [49] [50] [51] [52] Tip is expressed from the same transcript and interacts specifically with the T cellular tyrosine kinase Lck. 42 Both stpC and tip are necessary for T cell transformation. 40, 53 The viral mitogen ie14 is transcribed after additional stimulation of transformed T cells, but is dispensable for virus replication and human T cell transformation. 40 In contrast to transformed human T cells, their counterparts from New World monkeys such as cottontop tamarins (Saguinus oedipus) express all the viral genes and produce virion particles. 33 Correspondingly, we observed endogenous TK or GCV kinase activity in semipermissive-transformed simian T cells (Figure 4c ). This TK activity is presumably due to the expression of the viral genes orf21 and orf36, [54] [55] [56] which are typical functions in lytic virus replication and were found to be expressed under permissive conditions (Figure 3d ). When transformed simian T cells lost their permissivity to the virus, they also stopped to activate endogenously GCV in culture. In addition, the replication inhibition tests shown in Figure 2 indicated a comparably weak sensitivity of wild-type virus to GCV. This corresponds to the described low enzyme activities of the lytically expressed rhadinoviral genes orf21 and orf36. 55, 56 In tamarins, the infection by herpesvirus saimiri C488 leads to acute T cell lymphoma in which large amounts of virus are produced. 57, 58 In Old World primates (Macaca mulata and Macaca fascicularis) the reinfusion of large numbers of autologous, herpesvirus-transformed T cells was well tolerated, and no side-effects were noted, whereas the transfused T cells persisted for extended periods. 41 In conjunction with an active elimination mechanism, eg by the TK/GCV switch, this might form the basis for novel developments in allogeneic T cell therapy.
The TK/GCV prodrug activation system has been successfully used in a number of experimental and clinical applications (eg Refs 5, [17] [18] [19] [59] [60] [61] [62] . There are also many reports on successful applications of the CD/5-FC system (eg Refs 63-66). In our specific setting and in direct comparison of both suicide gene systems, the latter mechanism was completely inactive, although cd expression was confirmed on RNA and protein levels, and although the T cells were highly sensitive to 5-FU exposure. To our knowlege, this is the first study applying the CD/5-FC system in human T lymphocytes. Poor activity of the CD/5-FC system was also described in another study. 67 The lacking functionality of the CD/5-FC system in our hands may either be specific for T cells
Figure 5 Cre recombinase-mediated deletion of the neomycin resistance gene. The recombinant viruses TK-2 and TK-4 were passaged on Cre recombinaseexpressing OMK cells. SacII or ApaI-digested virion DNA was analyzed by Southern blot hybridization with either a radioactive tk or a neo r probe. After passage on Cre-expressing OMK cells, the LoxP site flanked neomycin resistance (neo r ) gene was efficiently deleted. Whereas the large SacII fragment was considerably shortened, the ApaI fragment was lost. Below a map of the tk/neo
r region is depicted.
or for the episomal herpesvirus vector system. In contrast, the efficacy of the TK-and CD-mediated druginduced kill was comparable in human EBV-transformed B cells; CD-mediated suicide was also functional, when EBV-based episomal vectors were used. 64, 66 A lower degree of basal susceptibility to GCV toxicity was observed in herpesvirus saimiri-transformed T cells lacking tk gene expression, when compared with primary, non-transformed T cells. This observation may be related to the spontaneous proliferation of transformed T cells in contrast to the tendency towards apoptosis after primary T cells have been stimulated.
In this study, we observed that virus recombinants with the TK transgene in (+) orientation were not efficient for transforming human T cells. In contrast, simian T cells were efficiently transformed also with the TK+ viruses to the semipermissive state. Although we cannot provide further experimental data to elucidate the mechanism, we speculate that the inefficiency of TK+ viruses may be specific for the non-permissive persistent state of infection, such as in human T cells. A particular configuration of an active transcription unit might interfere with the maintenance of episomal persistence. The H-/L-DNA transition region is one of the few possible candidates for the still unknown origin of the plasmid-like replication of persisting herpesvirus saimiri episomes.
Artificially introduced selection marker genes can be immunogenic and lead to efficient clearance of transduced cells by the immune system. 68 We have applied the Cre/LoxP system 69 in order to demonstrate that a secondary elimination of the neo r selection gene from herpesvirus saimiri vectors is easily possible, as soon as the selection gene is no longer necessary. The neo r gene was required for the generation and purification of recombinant virus. G418 selection was no longer applied to the infected human or simian T cells. Thus, the neo r gene was dispensable at this stage and successfully removed. However, the transforming function of the virus and the GCV sensitivity of transformed human T cells were fully maintained after removal of the neo r gene. Such manipulations are highly relevant in order to avoid an unwanted loss of efficacy due to cytotoxic T cells directed against the vector.
Herpesvirus saimiri was one of the first successful virus vectors used in preclinical gene transfer experiments. 25 Over the years, several improvements of the vector system have been presented. 26, 27, 70 Our recombination vector pRecosac is another step to facilitate the technique which allows recombination into herpesvirus saimiri genomes irrespective of the virus subgroup or the transforming features of the virus strain. In order to further adapt herpesvirus saimiri for therapeutic applications, we are studying the transduction properties of non-transforming versus transforming herpesvirus saimiri vectors into primary human T cells. Moreover, an immobilized replication-deficient vector variant would eliminate most concerns about biological safety. On the background of the technical problems with conventional retrovirus vectors concerning the reliable long-term function of the transduced gene in human T cells, we consider herpesvirus saimiri vectors to be a promising tool for developing a novel experimental immunotherapeutic approach in patients with rapidly progressive and highly resistant leukemia who do not have a realistic chance for cure with the currently available conventional therapy modalities. Herpesvirus-transduced functional alloreactive lympho-cytes may exert potent anti-leukemia effects while avoiding the risk of uncontrolled graft-versus-host disease, since the life span of alloreactive donor lymphocytes will be controlled by the effective and durable suicide gene expression from herpesvirus saimiri vectors.
Materials and methods

Vectors and recombinant herpesviruses
In order to facilitate the insertion of heterologous genes into the genome of herpesvirus saimiri by homologous recombination, the novel vector pRecosac was constructed which is an improved version of pSIneo. 27 The SacI site of the vector pBluescript M13 KS+ (Stratagene, Heidelberg, Germany) was converted to a KpnI site in order to allow the release of the vector backbone by a simple KpnI cleavage. A fragment of the coding nonrepetitive unique region (L-DNA) of herpesvirus saimiri was required to permit homologous recombination into the virus genome. A 5.5 kb terminal L-DNA SacII-SmaI fragment derived from the KpnIE segment of herpesvirus saimiri A11 54 was inserted into the SacII site of the plasmid vector. The SmaI site of the viral fragment had been changed to a SacII site before. A BamHI-PvuII fragment of pSV2neo harboring the neo r gene under control of SV40 transcription and termination signals was flanked by LoxP recognition sites for Cre recombinase 69 and inserted into the ApaI site of the vector. pRecosac harbors central unique cleavage sites for NotI, BamHI, ClaI and SalI. Expression cassettes for tk of HSV-1 or cd of E. coli were inserted into the SalI cleavage site. A tk expression construct (pGEM7TKSal) with the promoter and termination fragments of the murine phosphoglycerate kinase 1 gene (pgk-1) 71 was kindly provided by Kenji Imai (GSF, Neuherberg, Germany). The retroviral cd expression vector pCD2 65 was a gift from Michael Blaese (NIH, Bethesda, MD). The coding sequence of cd (EcoRI-BamHI fragment from pCD2) was placed under the same pgk-1 control sequences as used in the tk construct. The pgk-1 promoter-driven expression cassettes for tk and cd were inserted in both orientations into the SalI site of pRecosac to yield the recombination plasmids pRecoCD+, pRecoCD−, pRecoTK+ and pRecoTK− (Figure 1 ), which were confirmed by sequencing.
Herpesvirus saimiri mutants were generated by homologous recombination into the terminal transition region from coding L-DNA to terminal repetitive H-DNA. This method is based on earlier reports. 26, 27, 37, 40 The recombination plasmids based on pRecosac were cleaved with KpnI resulting in the release of the plasmid backbone. Linearized DNA of the recombination construct was transfected into subconfluent permissive owl monkey kidney cells (OMK; ATCC CRL-1556; Manassas, VA, USA) using lipofectamine (Gibco BRL, Karlsruhe, Germany). On the following day, the transfected OMK cells were split by a factor of 2 and infected with herpesvirus saimiri C488 at a multiplicity of infection of about 0.5. The resulting virus containing supernatants from lysed cultures was transferred to fresh OMK cells and passaged three times in the presence of increasing concentrations of G418 (Gibco BRL; 100, 200, 300 g/ml in Dulbecco's modified Eagle's medium with 10% heatinactivated fetal bovine serum). Virus grown under high G418 concentrations was plaque purified in 2% methyl Gene Therapy cellulose. Plaque-purified viruses were further amplified in OMK cells with 300 g/ml G418. The procedures largely followed published protocols. 37, 40, 58 Cell culture and T cell transformation OMK and T cell cultures were performed as previously published. 37 Non-transformed T cells from cottontop tamarin monkeys (Saguinus oedipus) were cultivated in the presence of 10 U/ml of recombinant interleukin-2 (IL-2) and periodically restimulated with equal cell numbers of irradiated (120 Gy) fresh human peripheral blood cells and Concanavalin A (ConA, 4 g/ml; Sigma, Deisenhofen, Germany) with intervals of at least 1 month. Human mononuclear cells from cord blood (CB) or from blood donations (No. 22, No. 28) were purified with ficoll density gradients, initially stimulated with ConA, and then cultivated in the presence of 50 U/ml IL-2. The IL-2 (Proleukin) used in this study was a gift from Chiron (Ratingen, Germany). On days 3-5 after the primary or secondary stimulation, human or simian T cells were infected with either wild-type or recombinant herpesvirus saimiri. Transformed human T cells were subjected to flow cytometry on a FACStrak machine using directly labeled standard monoclonal antibodies directed against CD3 (clone SK7), CD4 (clone SK3), and CD8 (clone SK1; Becton Dickinson, Heidelberg, Germany).
In virus replication and in T cell proliferation assays the following drugs were tested: ganciclovir (GCV; Cymeven; purchased from Syntex, Aachen, Germany); acyclovir (ACV; Zovirax; a gift from Glaxo Wellcome, Hamburg, Germany); 5-fluorocytosine (5-FC; purchased from Sigma; or Ancotil; a gift from Hoffmann-La Roche, Grenzach, Germany); and 5-fluorouracil (5-FU; purchased from Lederle, Mü nster, Germany). The influence of drugs on wild-type or recombinant virus replication was tested in quadruplicates in 24-well plates on OMK cells which were passaged the day before at an area ratio of 1:5. The virus supernatants (at least 10 6 tissue culture infectious doses per ml) were serially 10-fold diluted in complete medium and 1 ml was added per well. The drugs were added in 100 l as 10-fold concentrated solution in phosphate-buffered saline. As readout parameter, the respective dilution step was monitored which led to infection and complete lysis of the cells in at least two of the four parallel wells. The influence of the drugs was also tested on human and simian T cells which were transformed by either wild-type or recombinant virus. Simian T cells were seeded in 96-well flat-bottom microtiter plates at 100 000 cells per well and human T cells at 500 000 per well in 200 l complete medium without IL-2, either with or without the specific drugs. On day 6, 3 H thymidine (0.2 Ci in 20 l; Amersham, Braunschweig, Germany) was added to each of the triplicate microcultures. On day 7, the cultures were terminated with the cell harvester Matrix TM96 (Packard, Frankfurt, Germany). The dried glass fiber filters were exposed to 3 H sensitive screens and scanned with a BAS2000 imaging system (Fuji/Raytest, Straubenhardt, Germany). The measured values were converted to c.p.m. using a reference filter. Comparative measurements of the same filter with a direct ␤-counter and the BAS2000 showed a correlation of Ͼ0.95 and comparable sensitivities for both methods. 43 Analysis of transgene expressing recombinant viruses and cell lines Virus particles from 1 ml of supernatant were harvested by centrifugation and lysed with sodium dodecyl sulfate and proteinase K (Roche Biochemicals, Mannheim, Germany). Purified virion DNA was cleaved with appropriate restriction enzymes and transferred to nylon membranes. Southern blot filters were hybridized with 32 P random-labeled DNA probes of the entire tk, cd or neo r expression cassettes. RNase protection assays 33 were performed on total RNA samples (40 g; acidic phenol extraction method) from infected or virus-transformed cells. The probe plasmid based on pBluescript M13 KS+ (Stratagene) carried a 542 bp fragment harboring the pgk-1 promoter region from the StuI site at nucleotide position −303 relative to the start codon of the tk gene down to the SnaBI site within the tk coding sequence at nucleotide position +239 relative to the tk start codon. The probe plasmid was linearized and in vitro transcribed with T7 polymerase (Roche Biochemicals). Analogous RNase protection experiments were performed for the cd transgene. Total cellular DNA samples were prepared by digestion in PCR buffer with Tween 20 (0.5%) and proteinase K (100 g/ml) at 56°C for 2 h followed by boiling for 10 min. PCR for the tk transgene was done with the primers HF343 (5Ј-GCC-AAT-ACG-GTG-CGG-TAT-C-3Ј) and HF344 (5Ј-AAT-GGG-GTC-TCG-GTG-GGG-TAT-C-3Ј), and for the cd transgene with the primers HF237 (5Ј-CTG-TTC-TCC-TCT-TCC-TC-3Ј) and HF350 (5Ј-GGA-CAT-TTT-CAG-CAA-GCG-G-3Ј). Proteins from lysates of 10 7 T cells were separated on sodium dodecyl sulfate/12% polyacrylamide gels and transferred on nitrocellulose membranes. TK protein was stained with a rabbit antiserum 59 donated by David Gower (Glaxo Wellcome, Stevenage, UK). The monoclonal antibody 16D8F2 was used for the CD protein (a gift of the author). 63 Western blots were developed with standard chemoluminescence reactions.
The expression of the herpesvirus saimiri genes orf21 and orf36 was analyzed by RT-PCR. For this purpose, 30 g of total cellular RNA was digested with RNase-free DNase (Roche Diagnostics). Reverse transcription was performed with Superscript II (Gibco BRL) with 15 g of the DNase-digested RNA. Standard PCR was performed with the primers HF719 (5Ј-GAT-GAG-ACG-CAA-GTA-ACA-G-3Ј) and HF720 (5Ј-CAG-AAT-TAG-AAG-TGC-GAC-C-3Ј) for orf21 and with HF721 (5Ј-GTG-CGT-ATC-AGA-GAT-TTC-AG-3Ј) and HF722 (5Ј-GTT-ACC-AGA-GTG-TAG-AGA-G-3Ј) for orf36. In order to exclude false positive signals resulting from contaminating virus DNA, DNase-digested RNA samples were also subjected to PCR without previous reverse transcription, and were found to be free of residual virus DNA.
Targeted deletion by the Cre LoxP mechanism The SV2neo fragment was flanked by LoxP sequences and cloned as a component of the recombination construct pRecosac. The LoxP sites were generated using the following oligonucleotides: HF089 (5Ј-CTA-GAG-GGC-CCA-TAA-CTT-CGT-ATA-GCA-TAC-ATT-ATA-CGA-AGT-TAT-AT-3Ј), HF090 (5Ј-GAT-CAT-ATA-ACT-TCG-TAT-AAT-GTA-TGC-TAT-ACG-AAG-TTA-TGG-GCC-CT-3Ј), HF091 (5Ј-CGA-ATA-ACT-TCG-TAT-AGC-ATA-CAT-TAT-ACG-AAG-TTA-TAT-GGG-CC-3Ј), and HF092 (5Ј-CAT-ATA-ACT-TCG-TAT-AAT-GTA-TGC-TAT-ACG-AAG-TTA-TT-3Ј). Thus, the recombinant viruses derived from pRecosac also carried the neo r gene with flanking LoxP sites. In order to generate Cre-expressing permissive OMK cell lines, the neo r gene from pSV2neo was inserted into the KpnI cleavage site of the Cre recombinase plasmid pBS185 (purchased from Gibco BRL). 69 After linearization with EcoRI the plasmid DNA was transfected into OMK cells. G418-resistant OMK cell clones were amplified and functionally pretested by transient transfection with pRecosac plasmid DNA. Only in Cre-expressing OMK cells, the deletion of the 2.8 kb neo r fragment allowed the amplification of a 200 bp fragment by using the primers HF119 (5Ј-AAA-CGC-CCC-TTC-CCC-CTC-TTT-G-3Ј) and HF116 (5Ј-GCA-ATT-AAC-CCT-CAC-TAA-AGG-GAA-C-3Ј, a T3 primer) binding to pRecosac. Selected Cre-expressing OMK clones were used for infection with recombinant viruses.
